Clinical Trials
14 trialsNCT06890494 2026-03-10
Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia
Beijing GoBroad Hospital
Phase EARLY_PHASE1 Recruiting
NCT07429461 2026-02-24
Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia
Zhejiang University
Phase EARLY_PHASE1 Recruiting
NCT02356653 2026-02-20
ExpMACs
Children's Hospital of Philadelphia
Phase EARLY_PHASE1 Recruiting
NCT05049785 2025-07-25
Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT06904859 2025-04-01
The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia
Shenzhen University General Hospital
Phase EARLY_PHASE1 Completed
NCT06756321 2025-01-03
A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy
Affiliated Hospital of Nantong University
Phase EARLY_PHASE1 Recruiting
NCT06643221 2024-10-16
Allo-X
University of Arizona
Phase EARLY_PHASE1 Recruiting
NCT04504526 2023-09-15
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
NCT05519384 2022-11-28
Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase EARLY_PHASE1 Unknown
NCT00424242 2021-09-08
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
Northwestern University
Phase EARLY_PHASE1 Completed
NCT02331706 2020-04-21
IFN-DLI for Relapsed Acute Leukemia After Allo-SCT
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed
NCT00212407 2018-11-02
New York Blood Center National Cord Blood Program
New York Blood Center
Phase EARLY_PHASE1 Terminated
NCT00020670 2017-06-20
Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
Dana-Farber Cancer Institute
Phase EARLY_PHASE1 Terminated
NCT00437086 2014-10-17
Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders
Mayo Clinic
Phase EARLY_PHASE1 Completed